NCT03781557

Brief Summary

In this trial, the investigators are going to investigate the improvement of cognitive brain domains after ingestion of omega 3 products that have high concentrations of DHA, Docosahexaenoic acid, and EPA, Eicosapentaenoic acid, in comparison to control group young healthy adults. The study will assess the improvement by computerized testing by their reaction time before and after the intervention. The researchers will follow the scientific and ethical regulations prevent any harmful effect on recruited subjects.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2019

Shorter than P25 for phase_4

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2019

Completed
Last Updated

December 20, 2018

Status Verified

December 1, 2018

Enrollment Period

3 months

First QC Date

December 12, 2018

Last Update Submit

December 17, 2018

Conditions

Keywords

Omega-3DHA fatty acidsEPA fatty acidsCognitionBrainHealthy AdultFish OilHuman

Outcome Measures

Primary Outcomes (7)

  • Attention

    it will be measured by Psytest (TAP 2.3.1) computerised test to assess the reaction time related to it by milliseconds

    5 minutes

  • Working memory

    Working memory can be looked at as a system that keeps the information essential for solving difficult dilemmas and processing multi-level tasks or aspects of a situation in order to bring about a final impression. it will be measured by Psytest (TAP 2.3.1) computerised test to assess the reaction time related to it by milliseconds.

    5 minutes

  • Sustained attention

    it will be measured by Psytest (TAP 2.3.1) computerised test to assess the reaction time related to it by milliseconds.

    15 minutes

  • stimulus-reaction incompatibility (Simon effect)

    Incompatibility occurs in a conflict situation in which divergent stimulus information has to be processed in parallel, thus triggering different reaction tendencies. The Simon and the Stroop effects (in the Colour-Word Interference Test) are classic examples of this effect. The present procedure tests the interference tendency in terms of stimulus-reaction incompatibility (Simon effect) . For this test, arrows that are directed to the left or the right are presented on the left or the right of a fixation point. Depending on the direction of the arrow, the test person should respond with the right or left hand irrespective of the side on which the arrow is presented.

    3 minutes

  • Go/ No go

    this test will measure the specific ability of the subject to suppress an inappropriate response and to react only on the appearance of some stimuli and not in the presence of others, which requires significant central intervention. it will be measured by Psytest (TAP 2.3.1) computerised test to assess the reaction time related to it by milliseconds.

    5 minutes

  • Divided attention

    In this test, an auditory and a visual task must be taken simultaneously, to measure the subject's ability to carry out more than one task at the same time. it will be measured by Psytest (TAP 2.3.1) computerised test to assess the reaction time related to it by milliseconds.

    10 minutes

  • Alertness

    In this test, we will measure the reaction time. Simple reaction time measurements will be done, in which a diamond appears on the screen at random intervals and to which the subject should respond as quickly as possible by pressing a button. it will be measured by Psytest (TAP 2.3.1) computerised test to assess the reaction time related to it by milliseconds.

    5 minutes

Study Arms (3)

High-concentrated DHA

EXPERIMENTAL

High-concentrated DHA fish oil softgels

Dietary Supplement: Docosahexaenoic acid

High-concentrated EPA

EXPERIMENTAL

High-concentrated EPA fish oil softgels

Dietary Supplement: Eicosapentaenoic acid

Olive Oil

PLACEBO COMPARATOR

Olive Oil softgels

Dietary Supplement: Olive oil

Interventions

Docosahexaenoic acidDIETARY_SUPPLEMENT

High-concentrated DHA

Also known as: MadreLabs, DHA 700 Fish Oil
High-concentrated DHA
Eicosapentaenoic acidDIETARY_SUPPLEMENT

High-concentrated EPA

Also known as: Sports Research, Omega-3 Fish Oil, Triple Strength
High-concentrated EPA
Olive oilDIETARY_SUPPLEMENT

Olive Oil softgels

Olive Oil

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Young Adult (18-25)

You may not qualify if:

  • Diet rich in fish oil: subjects should not use a diet rich in omega 3 poly-unsaturated fatty acids, that is defined as more than one portion a week or more than 4 portions a month of the following food items
  • Salmon Sardines • Flaxseed oil or whole flaxseed Illicit drug use
  • Medications of mental illnesses or that affect brain functions
  • Fish Allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Docosahexaenoic AcidsEicosapentaenoic AcidFish OilsOlive Oil

Intervention Hierarchy (Ancestors)

Fatty Acids, Omega-3Dietary Fats, UnsaturatedDietary FatsFatsLipidsFatty Acids, UnsaturatedFatty AcidsOilsEicosanoidsFats, UnsaturatedPlant OilsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Central Study Contacts

WESAM ALKASSAS, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2018

First Posted

December 20, 2018

Study Start

January 1, 2019

Primary Completion

April 1, 2019

Study Completion

May 29, 2019

Last Updated

December 20, 2018

Record last verified: 2018-12